1. Catalog
  2. ORN Summer 2024 - Clinical Implications of the Rel ...
Image For Activity Cover
ORN Summer 2024 - Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
Description:

This lecture is on the effects of Naltrexone in people with Opioid Use Disorder, taking medication levels into consideration.

Learning objectives:
At the conclusion of this seminar, attendees should be able to:
  1. List and describe the three FDA-approved medications for OUD. 
  2. Explain the mechanism of action of extended-release naltrexone (XR-NTX).
  3. List the benefits of XR-NTX in patients with OUD.
  4. Identify the minimally effective level of naltrexone (NTX).
  5. Describe how the therapeutic effect is dependent on NTX plasma level.
Claim Credits & Course Materials

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
What is ORN
Speaker:
Felipe Castillo, MD

Felipe Castillo, MD received BA from Cornell University, MD from Tulane University and completed his Adult Psychiatry residency at Montefiore Medical Center in the Bronx, NY. Completed an NIH T32 and ACGME Addiction Psychiatry fellowship at Columbia University/New York State Psychiatric Institute with the Division on Substance Use Disorders, pursuing both research and clinical interests in addiction.
He has researched topics ranging from attitudes towards Medications for Opioid Use Disorder (MOUDs) by clinicians to the role that comorbid drug use plays among patients with Opioid Use Disorder (OUD) initiating treatment.
DISCLAIMER

ACCREDITATION:
This actvity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association and The American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:
The American Osteopathic Association designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding:

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary
Availability: No future session
Expires on Aug 01, 2027
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Create Account
Recommended
Powered By